JHL Biotech financials at a glance
| Year | Year | 2015 | 2016 | 2017 | 2018 | 2014 | 2013 | 2020 | 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
29.75M | 248.01M | 359.12M | 0.00M | 11.42M | 0.00M | 0.00M | 0.00M |
| GM % | Gross Margin % |
|
18.49% | 41.15% | 9.44% | 0.00% | 62.81% | 0.00% | 0.00% | 0.00% |
| OM | Operating Margin |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | Earnings Per Share |
|
0.00 | 0.00 | 0.00 | |||||
| Div. | Dividends |
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sha. | Shares |
|
189.09m | 190.85m | 220.17m | 220.4m | 0m | 0m | 0m | 0m |
| OCF | Operating Cash Flow |
|
-508.18M | -336.14M | -1045.21M | 0.00M | -259.42M | -86.61M | 0.00M | 0.00M |
| FCF | Free Cash Flow |
|
-1093.01M | -1047.53M | -1288.01M | 0.00M | -884.05M | -323.13M | 0.00M | 0.00M |
| FCFS | Free Cash Flow Per Share |
|
-7.79 | -5.53 | -5.90 | 0.00 | -121.31 | -139.10 | 0.00 | 0.00 |